Schilke Tobin
CIK 1678984
Transactions on file
10
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-09-01 | 2026-09-01 | CRNX Crinetics Pharmaceuticals, Inc. | Officer Chief Financial & Infra. Ofcr. | Disp. | 71,471 | $6.08M | -0.1% | open → |
| 2026-09-01 | 2026-09-01 | CRNX Crinetics Pharmaceuticals, Inc. | Officer Chief Financial & Infra. Ofcr. | Disp. | 7,956 | $676.3K | -0.1% | open → |
| 2026-08-25 | 2026-08-20 | CRNX Crinetics Pharmaceuticals, Inc. | Officer Chief Financial & Infra. Ofcr. | Grant | 471 | $0.00 | — | open → |
| 2025-01-03 | 2024-12-31 | RVNC Revance Therapeutics, Inc. | Officer CFO | Grant | 1,000 | $2.2K | — | open → |
| 2025-02-05 | 2025-02-03 | RVNC Revance Therapeutics, Inc. | Officer CFO | Grant | 6,888 | $0.00 | — | open → |
| 2025-02-06 | 2025-02-06 | RVNC Revance Therapeutics, Inc. | Officer CFO | Grant | 20,883 | $0.00 | — | open → |
| 2025-02-06 | 2025-02-06 | RVNC Revance Therapeutics, Inc. | Officer CFO | Disp. | 103,555 | — | — | open → |
| 2025-02-06 | 2025-02-04 | RVNC Revance Therapeutics, Inc. | Officer CFO | U | 97,999 | $357.7K | — | open → |
| 2025-02-06 | 2025-02-06 | RVNC Revance Therapeutics, Inc. | Officer CFO | Disp. | 20,883 | — | — | open → |
| 2025-03-11 | 2025-03-10 | CRNX Crinetics Pharmaceuticals, Inc. | Officer Chief Financial Officer | Grant | 52,000 | $0.00 | — | open → |
